News & Updates
Showing Pharmacy articles
Showing

Older IBD patients at disadvantage for medications, surgery
Older patients with inflammatory bowel disease (IBD) are less likely to be initiated on medications and are often scheduled for surgeries, a study has found.
Older IBD patients at disadvantage for medications, surgery
29 Apr 2023
Clindamycin delivers in bacterial vaginosis
Use of a single dose of a new bioadhesive 2% clindamycin vaginal gel in the treatment of bacterial vaginosis appears to result in a rapid resolution of symptoms, with high acceptability among women, as reported in a study.
Clindamycin delivers in bacterial vaginosis
29 Apr 2023
Tralokinumab a promising treatment option in young people with moderate-to-severe AD
Targeting interleukin (IL)-13 with tralokinumab monotherapy helps reduce disease activity in adolescents with moderate-to-severe atopic dermatitis (AD) with a low frequency of conjunctivitis throughout the treatment period, according to data from the phase III ECZTRA 6 trial.
Tralokinumab a promising treatment option in young people with moderate-to-severe AD
29 Apr 2023
Laser acupuncture plus vitamins beneficial in postmenopausal women with osteoporosis
Laser acupuncture, when combined with supplementation with calcium and fluoride-containing vitamin D, appears to increase forearm bone mineral density and reduce wrist pain in postmenopausal women with osteoporosis, according to the results of a randomized controlled trial.
Laser acupuncture plus vitamins beneficial in postmenopausal women with osteoporosis
28 Apr 2023
Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab
In patients with locally advanced or metastatic urothelial cancer patients receiving atezolizumab treatment, immune-related adverse events (AEs) were associated with improved survival outcomes, according to an analysis of individual participant data from the IMvigor210 and IMvigor211 studies.
Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab
27 Apr 2023
Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax
The bivalent mRNA-1273.214 booster vaccine provides superior immunogenicity compared with the original COVID-19 mRNA-1273 vaccine in a phase III study, according to an expert who presented at ECCMID 2023.



